Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905148-24-002638
Filing Date
2024-10-03
Accepted
2024-10-03 18:57:44
Documents
2
Period of Report
2024-09-27

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 4513
2 poa_swanson.htm EX-24 8923
  Complete submission text file 0000905148-24-002638.txt   15145
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Issuer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PROTHENA BIOSCIENCES INC. 1800 SIERRA POINT PARKWAY BRISBANE CA 94005
Business Address
Swanson Chad J. (Reporting) CIK: 0002038509 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35676 | Film No.: 241353043